Sullivan P, Kumar R, Li W, Hoglund V, Wang L, Zhang Y, et al. FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma. Mol Cancer Ther. 2022;21:1608-1621 pubmed publisher

Timpanaro A, Piccand C, Uldry A, Bode P, Dzhumashev D, Sala R, et al. Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. Int J Mol Sci. 2023;24: pubmed publisher

Ramesh P, Di Franco S, Atencia Taboada L, Zhang L, Nicotra A, Stassi G, et al. BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer. Cell Rep. 2022;38:110374 pubmed publisher

Vrijens P, Noppen S, Boogaerts T, Vanstreels E, Ronca R, Chiodelli P, et al. Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway. J Gen Virol. 2019;100:583-601 pubmed publisher

Alves B, Cardoso R, Prezotto L, Thorson J, Bedenbaugh M, Sharpton S, et al. Elevated body weight gain during the juvenile period alters neuropeptide Y-gonadotropin-releasing hormone circuitry in prepubertal heifers. Biol Reprod. 2015;92:46 pubmed publisher

Heinzle C, Gsur A, Hunjadi M, Erdem Z, Gauglhofer C, Stättner S, et al. Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasis. Cancer Res. 2012;72:5767-77 pubmed publisher